Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA
Detection Principle
NucleicAcid-PCR based
Target
N gene (LDT); ORF1ab, E (Cobas); ORF1ab, N (AmpliDiag)
Testing Method Category
PCR_KIT
Testing Method
kit & in house
Testing Method - Additional Info
LDT , cobas® SARS-CoV-2 (Roche), Amplidiag® COVID-19 (Mobidiag)
Reported Performance
PPA: 100% (Cobas), 98.9% (AmpliDiag and LDT); NPA:89.4% (Cobas), 98.8% (AmpliDiag), 100% (LDT)
Sample Size
183 samples
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements